Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety Mallet, Eric
2004
22 11-12 p. 1343-1357
15 p.
artikel
2 Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster Mallet, Eric
2004
22 11-12 p. 1415-1422
8 p.
artikel
3 Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines Leitner, Wolfgang W
2004
22 11-12 p. 1537-1544
8 p.
artikel
4 Cell death induced by vaccine adjuvants containing surfactants Yang, Ya-Wun
2004
22 11-12 p. 1524-1536
13 p.
artikel
5 Editorial Board/Aims and Scope 2004
22 11-12 p. IFC-
1 p.
artikel
6 Erratum to “Loss of imunity to pertussis in a rural community in Senegal” [Vaccine 22 (2004) 594–596] Broutin, Hélène
2004
22 11-12 p. 1587-
1 p.
artikel
7 Erratum to “Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer” [Vaccine 22 (2004) 64–69] Bergfors, Elisabet
2004
22 11-12 p. 1586-
1 p.
artikel
8 Evaluation of the impact of an HMO’s varicella vaccination program on incidence of varicella Mullooly, John P
2004
22 11-12 p. 1480-1485
6 p.
artikel
9 Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle Kalina, Warren V.
2004
22 11-12 p. 1465-1474
10 p.
artikel
10 Fourth World Congress on Vaccines and Immunisation, 30 September-3 October 2004, Tsukuba Science City, Tokyo, Japan WCVI 2004 Japan 2004
22 11-12 p. I-II
nvt p.
artikel
11 Gene immunization may induce secondary antibodies reacting with DNA Isaguliants, Maria G
2004
22 11-12 p. 1576-1585
10 p.
artikel
12 Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A Tiberio, Lorrie
2004
22 11-12 p. 1515-1523
9 p.
artikel
13 Immunisation against PCV2 structural protein by DNA vaccination of mice Kamstrup, Søren
2004
22 11-12 p. 1358-1361
4 p.
artikel
14 Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis Haile, M
2004
22 11-12 p. 1498-1508
11 p.
artikel
15 Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice Strindelius, Lena
2004
22 11-12 p. 1448-1456
9 p.
artikel
16 Influence of routes and administration parameters on antibody response of pigs following DNA vaccination Barfoed, Annette Malene
2004
22 11-12 p. 1395-1405
11 p.
artikel
17 In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine Wu, Chang-Jer
2004
22 11-12 p. 1457-1464
8 p.
artikel
18 Leptospiral immunoglobulin-like proteins elicit protective immunity Koizumi, Nobuo
2004
22 11-12 p. 1545-1552
8 p.
artikel
19 Localization of linear cytotoxic and pro-apoptotic epitopes in RTX toxin ApxIII of Actinobacillus pleuropneumoniae Seah, J.N.
2004
22 11-12 p. 1494-1497
4 p.
artikel
20 Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant Soenawan, Elawati
2004
22 11-12 p. 1553-1563
11 p.
artikel
21 Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant Iyer, Seema
2004
22 11-12 p. 1475-1479
5 p.
artikel
22 Mouse neurotoxicity test for vaccinia-based smallpox vaccines Li, Zhongqi
2004
22 11-12 p. 1486-1493
8 p.
artikel
23 Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8+ T cell population in different tissues Qimron, Udi
2004
22 11-12 p. 1390-1394
5 p.
artikel
24 Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter Wyszyńska, Agnieszka
2004
22 11-12 p. 1379-1389
11 p.
artikel
25 Persistence of antibodies at 5–6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5–6 years of age Langue, Jacques
2004
22 11-12 p. 1406-1414
9 p.
artikel
26 Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status Linder, Nehama
2004
22 11-12 p. 1509-1514
6 p.
artikel
27 Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles Carcaboso, A.M
2004
22 11-12 p. 1423-1432
10 p.
artikel
28 Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides Langhans, Bettina
2004
22 11-12 p. 1441-1447
7 p.
artikel
29 Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography Özcengiz, Erkan
2004
22 11-12 p. 1570-1575
6 p.
artikel
30 Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response Humphries, Holly E
2004
22 11-12 p. 1564-1569
6 p.
artikel
31 Review of pneumococcal conjugate vaccine in adults: implications on clinical development Abraham-Van Parijs, Betsy
2004
22 11-12 p. 1362-1371
10 p.
artikel
32 Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus Eblé, Phaedra L
2004
22 11-12 p. 1372-1378
7 p.
artikel
33 Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection Aricò, Eleonora
2004
22 11-12 p. 1433-1440
8 p.
artikel
34 Viral Vaccine meeting held in Barcelona, October 25–28, 2003 Boon, A.C.M
2004
22 11-12 p. 1327-1334
8 p.
artikel
35 What is vaccine advocacy? Balinska, M.A.
2004
22 11-12 p. 1335-1342
8 p.
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland